Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by MetLife Investment Management LLC

MetLife Investment Management LLC reduced its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 1.5% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 21,938 shares of the biotechnology company’s stock after selling 328 shares during the period. MetLife Investment Management LLC’s holdings in Axon Enterprise were worth $8,766,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. Massachusetts Financial Services Co. MA purchased a new position in shares of Axon Enterprise in the 3rd quarter valued at approximately $120,553,000. International Assets Investment Management LLC purchased a new position in Axon Enterprise in the 3rd quarter valued at $871,860,000. Westfield Capital Management Co. LP increased its stake in Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after buying an additional 127,769 shares during the period. 1832 Asset Management L.P. raised its position in Axon Enterprise by 44.0% during the 2nd quarter. 1832 Asset Management L.P. now owns 375,700 shares of the biotechnology company’s stock worth $110,546,000 after buying an additional 114,800 shares during the last quarter. Finally, Champlain Investment Partners LLC lifted its stake in shares of Axon Enterprise by 13.9% in the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock worth $272,695,000 after acquiring an additional 83,265 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on AXON. Robert W. Baird boosted their price target on shares of Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Barclays boosted their target price on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. JMP Securities lifted their price target on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. The Goldman Sachs Group increased their price objective on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Finally, Needham & Company LLC boosted their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and a consensus target price of $427.83.

Insiders Place Their Bets

In other news, CFO Brittany Bagley sold 4,338 shares of the company’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the completion of the transaction, the chief financial officer now owns 98,825 shares of the company’s stock, valued at $37,449,733.75. This represents a 4.20 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Patrick W. Smith sold 75,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $356.53, for a total transaction of $26,739,750.00. Following the completion of the sale, the chief executive officer now directly owns 2,970,366 shares in the company, valued at $1,059,024,589.98. This represents a 2.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 210,256 shares of company stock valued at $87,783,120 in the last ninety days. Insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Up 0.4 %

Shares of NASDAQ:AXON opened at $634.96 on Friday. The company has a market capitalization of $48.42 billion, a P/E ratio of 164.07, a P/E/G ratio of 13.97 and a beta of 0.94. The stock’s fifty day simple moving average is $478.27 and its 200-day simple moving average is $374.80. Axon Enterprise, Inc. has a 52-week low of $224.28 and a 52-week high of $641.20. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.